| 1. |
|
|
| 2. |
|
|
| 3. |
|
|
| 4. |
- Diaz-Ravina, M, et al.
(författare)
-
Tolerance (PICT) of the bacterial communities to copper in vineyards soils from Spain
- 2007
-
Ingår i: Journal of Environmental Quality. - : Wiley. - 0047-2425. ; 36:6, s. 1760-1764
-
Tidskriftsartikel (refereegranskat)abstract
- To detect effects of Cu pollution, the Cu tolerance of soil bacterial communities extracted from several vineyards located in NW Spain was measured. Bacterial community tolerance was estimated by means of the thymidine (TdR) and leucine (Leu) incorporation techniques using either IC50 values (the log of the metal concentration that reduced incorporation to 50%) or the percentage of activity at one specific Cu concentration (10(-6) mol L-1 )The tolerance measurements by the TdR incorporation technique were similar to those obtained by the Leu incorporation method, indicating that the two methods were equivalent in terms of suitability for detecting the toxicity of Cu to soil bacterial communities. The two tolerance indices considered (IC50 values and percentage of activity) were closely correlated (r = 0.975, P < 0.001), showing that both were equally good in measuring Cu tolerance of the bacterial community. An increased bacterial community tolerance to Cu indicating a pollution effect, was observed in vineyard soils with more than 100 mg Cu kg(-1) soil. Thus, the long-term use of Cu in vineyards has a toxic effect on the soil bacterial community, resulting in an increased tolerance. An effect of increased levels of Cu could not be detected when measuring bacterial community activity, pointing to the increased sensitivity to detect toxicity in field studies using tolerance measurements.
|
|
| 5. |
|
|
| 6. |
|
|
| 7. |
|
|
| 8. |
|
|
| 9. |
- Pour, Aghaei Payam, et al.
(författare)
-
Brain-computer interface : Next generation thought controlled distributed video game development platform
- 2008
-
Konferensbidrag (refereegranskat)abstract
- In this paper we present a system that uses the human ability to control a video game on a mobile device using electroencephalographic (EEG) Mu rhythms. The signals were obtained using a specially designed electrode cap and equipment, and sent through a Bluetooth connection to a pc that processes it in real time. The signal was then mapped onto two control signals and sent through wireless connection to a mobile gaming device BreakOuC. We have also inv~stiga~ed the human's ability to play the video game by mampulatmg neuronal motor cortex activity in the presence of a visual feedback environment. The participants played the video game by using their thoughts only with up to 80% accuracy overcontrolling the target.
|
|
| 10. |
- Reginster, JY, et al.
(författare)
-
Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men
- 2006
-
Ingår i: Osteoporosis International. - : Springer Science and Business Media LLC. - 1433-2965 .- 0937-941X. ; 17:1, s. 41281-41281
-
Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
- Recent advances in the understanding of the epidemiology of osteoporosis suggest that certain parts of the current European guidelines for the registration of drugs in osteoporosis might be no longer substantiated. The object of this review is to provide the European regulatory authorities with an evidence-based working document providing suggestions for the revision of the "Note for guidance for the approval of drugs to be used in postmenopausal osteoporosis" (CPMP/EWP/552/95). Following an extensive review of the literature (1990-2004), the Group for the Respect of Ethics and Excellence in Science (GREES) organized a workshop including European regulators, academic scientists and representatives of the pharmaceutical industry. The outcomes of this meeting reflect the personal views of those who attended and should not, in any case, be seen as an official position paper of any regulatory agency. The group identified a certain number of points that deserve discussion. They mainly relate to the nature of the indication being granted to new chemical entities (treatment of osteoporosis in women at high risk of fracture instead of prevention and treatment of osteoporosis), the requirements of showing an anti-fracture efficacy on all or on major nonvertebral fractures (instead of the hip), the duration of pivotal trials (2 years instead of 3) and the possibility of considering bridging studies for new routes of administration, new doses or new regimens of previously approved drugs. The group also recommends that an indication could be granted for the treatment of osteoporosis in males on the basis of a placebo-controlled study, with bone mineral density changes after 1 year as the primary endpoint, for medications approved in the treatment of osteoporosis in women at high risk of fractures.
|
|
